Solitaire Trumped Merci in Stroke Clot Retrieval Trial
February 3, 2012|Clinical Neurology News
Author and Disclosure Information
FROM THE INTERNATIONAL STROKE CONFERENCE
Solitaire has already been approved in Europe. These new data should help propel it to a U.S. approval, he said.
"The data from this trial have been submitted to the Food and Drug Administration, and we are hopeful that within a few weeks or months these results will allow the FDA to approve it in the U.S."
Ev3, the company that makes Solitaire, funded the SWIFT trial. Dr. Saver disclosed that he is on the company’s speakers advisory board.
